Medicenna Therapeutics Corp. Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Medicenna Therapeutics Corp. (MDNAF) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of 1.44 CAD/shares for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2023-06-27
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2023-03-31 | 1.44 CAD/shares 20-F · filed 2023-06-27 |
| 2022-03-31 | 3.55 CAD/shares 20-F · filed 2023-06-27 |
| 2021-03-31 | 5.14 CAD/shares 20-F · filed 2023-06-27 |
| 2020-03-31 | 1.38 CAD/shares 20-F · filed 2022-06-22 |
| 2019-03-31 | 1.00 CAD/shares 40-F · filed 2021-05-28 |